Dose Range Study of Pharmacokinetics, Safety, and Preliminary Antiviral Activity of Emtricitabine in Adults with Hepatitis B Virus Infection

A multicenter, open-label study was performed to evaluate the safety, anti-hepatitis B virus (anti-HBV) activity, and pharmacokinetics of emtricitabine therapy administered once daily for 8 weeks to patients infected with HBV. Clinical and virologic evaluations were completed at the baseline; at 7,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gish, R. G., Leung, N. W. Y., Wright, T. L., Trinh, Huy, Lang, W., Kessler, H. A., Fang, L., Wang, L. H., Delehanty, J., Rigney, A., Mondou, E., Snow, A., Rousseau, F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2002
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC127249/
https://ncbi.nlm.nih.gov/pubmed/12019083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.6.1734-1740.2002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi